Skip to main content

GeneWiz Receives CLIA Certification

NEW YORK (GenomeWeb News) – DNA testing contract research organization GeneWiz today said that it has obtained Clinical Laboratory Improvement Amendments licensure and certificate of registration from New Jersey, allowing it to offer clinical genomic testing.

In addition to KRAS and EGFR tests, the company plans to continue developing CLIA-certified assays based on traditional platforms as well as new technologies, such as next-generation sequencing, it said.

GeneWiz added that it recently expanded its laboratory operations at its South Plainfield, NJ, headquarters to include a clean suite dedicated to processing clinical and preclinical samples. The laboratory will allow the company to expand its services into biologic drug and cell bank characterization testing, clinical trial investigations, and clinical diagnostic testing.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.